T8	Subject 0 26	A 38-year-old white female
T11	Treat-Disorder 175 245	methicillin-resistant Staphylococcus aureus (MRSA) pulmonary infection
T12	Age 2 13	38-year-old
T13	Race 14 19	white
T14	Gender 20 26	female
T15	Treat-Disorder 32 47	cystic fibrosis
T16	Dosage 73 83	300 mg/day
T17	Drug 61 72	venlafaxine
T18	Drug 112 121	linezolid
T19	Dosage 122 128	600 mg
T20	Freq 143 157	every 12 hours
T21	Route 129 142	intravenously
T9	Potential_therapeutic_event 48 55	treated
E1	Potential_therapeutic_event:T9 arg:T8 arg2:T1
T2	Duration 88 96	one year
T1	Treatment 61 96	venlafaxine 300 mg/day for one year
R1	has Arg1:T1 Arg2:T15	
T3	Potential_therapeutic_event 162 171	treatment
E2	Potential_therapeutic_event:T3 arg:T8 arg2:T4
T4	Treatment 112 157	linezolid 600 mg intravenously every 12 hours
R2	has Arg1:T4 Arg2:T11	
